KMT2C c.12241dup ;(p.S4081Ffs*12)

Variant ID: 7-151851129-G-GA

NM_170606.2(KMT2C):c.12241dup;(p.S4081Ffs*12)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors.

Theranostics
Shi, Zhiwen Z; Shen, Jianfeng J; Qiu, Junjun J; Zhao, Qingguo Q; Hua, Keqin K; Wang, Hongyan H
Publication Date: 2021

Variant appearance in text: MLL3: 12240_12240insT
PubMed Link: 34158843
Variant Present in the following documents:
  • thnov11p7175s3.xlsx, sheet 1
View BVdb publication page